🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Worries

However, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.

Several professionals said the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Elimination

According to the social media company, the service has removed problematic material and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Research also discovered communities with up to 9,000 members selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or administering at residence.

After moments of entering one community, a vendor shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Within these communities, posts display black plastic packages with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to possibly significant medical dangers”.